Become a part of the Department that touches the lives of every American! At the Department of Health and Human Services (HHS) you can give back to your community, state, and country by making a difference in the lives of Americans everywhere. It is the principal agency for protecting the health of citizens. Join HHS and help to make our world healthier, safer, and better for all Americans.
This position is located in the Department of Health and Human Services (HHS), Food and Drug Administration (FDA), Office of In Vitro Diagnostics and Radiological Health (CDRH), Division of Molecular Genetics and Pathology (DMGP), Molecular Pathology and Cytology Branch in Silver Spring, Maryland.
This vacancy is also being announced concurrently with vacancy announcement FDA-CDRH-17-MP-1969403MB under merit promotion procedures. Please review that announcement to see if you are eligible for consideration under merit promotion procedures.
NOTE: Applicants must apply separately for each announcement in order to be considered.
Who May Apply: Open to all United States Citizens.
Additional selections may be made within the same geographical area FDA-wide.
If selected for this position, you will:
- Serve as a recognized authority or consultant for scientific program studies or issues which are considered to be one of the most difficult and complex in nature in terms of their scientific or technical implications;
- Plan, manage, enforce, develop and interpret post-market laws, regulations and policies related to cytology in vitro diagnostic medical devices;
- Work independently and lead reviews and evaluation of scientific data submitted to the Agency by industry to determine the safety and effectiveness of high level and complex cytology medical devices. The duties consist of evaluating scientific data, as well as the test methods and descriptions of devices contained in medical device submissions from industry to the Agency;
- Coordinate and integrate the planning, programming, development, oversight, scheduling and overall management of resources for health science-related regulatory inspections, investigations, projects, or programs in areas where precedents and guidelines are inadequate.